Journal Home
Search for

Volume 47, Issue 5, Pages 924-927 (May 2008)


View previous. 10 of 64 View next.

Elective endovascular and open repair of abdominal aortic aneurysms in octogenarians

Presented at the Midwestern Vascular Surgical Society, Chicago, Ill, Sept 6-8, 2007.

David Paolini, MD, Santiago Chahwan, MD, Dennis Wojnarowski, BA, John P. Pigott, MD, Frankie LaPorte, MS, Anthony J. Comerota, MDCorresponding Author Informationemail address

Received 20 September 2007; accepted 13 December 2007. published online 25 March 2008.

Objectives

Endovascular aortic aneurysm repair (EVAR) is an increasingly popular treatment option for patients with abdominal aortic aneurysms (AAA), although open repair is considered the standard by virtue of its durability. Octogenarians, as a subgroup, may stand to benefit the most by EVAR. The purpose of this study is to review operative results and durability of open AAA repair and EVAR in octogenarians.

Methods

From May 1996 to August 2006, 150 patients aged ≥80 years underwent elective repair of their infrarenal AAA. Eighty-one underwent EVAR and 69 had open repair. Demographic data, aneurysm specifics, comorbidities, operative morbidity and mortality, intensive care unit and hospital length of stay, and late outcomes were analyzed.

Results

In the EVAR group, 27 of 81 (33%) patients died during a mean follow-up of 25 months. In the open repair group, 34 of 69 (49%) patients died during a mean follow-up of 43 months. The median survival time for EVAR was 350 weeks (range, 145-404 weeks) compared with 317 weeks (range, 233-342 weeks) for the open repair group. A Kaplan-Meier log-rank analysis showed no difference in early or long-term survival between EVAR and open repair (P = .13). EVAR was associated with decreased blood loss, decreased length of intensive care unit and hospital stays, and a greater number of patients discharged to home.

Conclusions

EVAR and open repair are comparable in safety and efficacy in octogenarians. Operative repair outcomes remain acceptable. Mid- and long-term survival are similar, indicating no survival advantage of one procedure compared with the other.

Jobst Vascular Center, Toledo, Ohio.

Corresponding Author InformationReprint requests: Anthony J. Comerota, MD, FACS, Jobst Vascular Center, 2109 Hughes Dr, Ste 400, Toledo, OH 43606.

 Competition of interest: none.

PII: S0741-5214(07)02053-8

doi:10.1016/j.jvs.2007.12.034


View previous. 10 of 64 View next.